ENGLEWOOD, Colo.–(BUSINESS WIRE)–Paragon 28, Inc. (NYSE: FNA), a leading medical device company exclusively focused on the foot and ankle orthopedic market, today announced the launch of its Monkey Rings™ Circular External Fixation System for trauma, deformity correction, and limb salvage.
The Monkey Rings Circular External Fixation System is designed to use external wires and screws that can be fixed into bone to maintain anatomic position while providing stability, preservation of soft tissue, and allow for adjustability and functionality. The Monkey Rings™ System allows hospitals and surgeons to work with a single vendor for internal fixation, external fixation, wound care, and biologics.
Paragon 28’s CEO, Albert DaCosta, commented. “P28 is committed to commercializing technologies to enable better outcomes for foot and ankle patients, and the launch of the Monkey Rings Circular External Fixation is another significant step in the fulfillment of our mission. Combined with the launch of the Monkey Bars Pin-to Bar External Fixation System earlier this year, we are building out a strong external fixation portfolio and complementing our comprehensive internal fixation, biologics and soft tissue options.”
The addition of the Monkey Rings™ Circular External Fixation System bolsters Paragon 28’s product offering which includes the Silverback® Ankle Fusion Plating System, Gorilla® R3CON Plating System, Joust™ Beaming Screw System, APEX 3D™ Total Ankle Replacement System, and Phantom™ TTC Fusion Nail Systems. With this comprehensive portfolio, Paragon 28 provides its customers a broad array of innovative solutions for deformity correction, arthritis, trauma, and limb salvage.
Based in Englewood, CO., Paragon 28, is a leading medical device company exclusively focused on the foot and ankle orthopedic market and is dedicated to improving patient lives. From the onset, Paragon 28® has provided innovative orthopedic solutions, procedural approaches and instrumentation that cover a wide range of foot and ankle ailments including fracture fixation, hallux valgus (bunions), hammertoe, ankle, progressive collapsing foot deformity (PCFD) or flatfoot, charcot foot and orthobiologics. The company designs products with both the patient and surgeon in mind, with the goal of improving outcomes, reducing ailment recurrence and complication rates, and making the procedures simpler, consistent, and reproducible.
Contacts Investor Contact: Gilmartin Group Matt Bacso, CFA firstname.lastname@example.org
Your email address will not be published. Required fields are marked *
Notify me of follow-up comments by email.
Notify me of new posts by email.
This site uses Akismet to reduce spam. Learn how your comment data is processed.
What are you expectations for the Orthopedic and Spine industry for 2019?